US20160362489A1 - Treatment of PD-L1-Positive Melanoma Using an Anti-PD-1 Antibody - Google Patents

Treatment of PD-L1-Positive Melanoma Using an Anti-PD-1 Antibody Download PDF

Info

Publication number
US20160362489A1
US20160362489A1 US15/141,772 US201615141772A US2016362489A1 US 20160362489 A1 US20160362489 A1 US 20160362489A1 US 201615141772 A US201615141772 A US 201615141772A US 2016362489 A1 US2016362489 A1 US 2016362489A1
Authority
US
United States
Prior art keywords
pd
anti
antibody
l1
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US15/141,772
Inventor
Arvin YANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201562153954P priority Critical
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to US15/141,772 priority patent/US20160362489A1/en
Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: YANG, Arvin
Publication of US20160362489A1 publication Critical patent/US20160362489A1/en
Application status is Pending legal-status Critical

Links